Skip to main content

Duffy Sean P.'s Form 4 filing

Omada Health, Inc. (OMDA) · filed Sep 3, 2026

Accession no.
0001610717-26-000397
Filed
Sep 3, 2026, 6:20 PM ET
Trade date
Sep 1, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 3 derivative transactions. Open-market sales total $509.5K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Duffy Sean P.CIK 0002069522Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 1, 2026Common StockMOption exerciseAcquired+12,944$5.82+$75,334.08424,805Direct
Sep 1, 2026Common StockMOption exerciseAcquired+4,314$8.28+$35,719.92429,119Direct
Sep 1, 2026Common StockMOption exerciseAcquired+4,314$9.18+$39,602.52433,433Direct
Sep 1, 2026Common StockSSaleDisposed−7,344$23.12F2−$169,781.53426,089Direct
Sep 1, 2026Common StockSSaleDisposed−5,600$24.27F3−$135,900.8420,489Direct
Sep 1, 2026Common StockSSaleDisposed−4,933$23.13F4−$114,100.29415,556Direct
Sep 1, 2026Common StockSSaleDisposed−3,695$24.27F5−$89,682.45411,861Direct
Sep 1, 2026Common StockFTax withholdingDisposed−9,885$22.84−$225,773.4401,976Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 1, 2026Common StockMOption exerciseDisposed−12,944$0.00$0129,539Direct
Sep 1, 2026Common StockMOption exerciseDisposed−4,314$0.00$0106,218Direct
Sep 1, 2026Common StockMOption exerciseDisposed−4,314$0.00$0512,994Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $22.69 to $23.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $23.75 to $24.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $22.71 to $23.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $23.76 to $24.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)